CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- 144/A Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President and COO sold 696 shares at $21.50 ($14,965)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,115 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 670 shares (to pay taxes)
- 4 Open-market sale Chief Scientific Officer sold 548 shares at $21.50 ($11,783)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,339 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes CFO and Treasurer gave up 2,743 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 4,352 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,642 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,131 shares (to pay taxes)
- 4 Open-market sale Chief Scientific Officer sold 754 shares at $20.29 ($15,299)
Page 6 of 34 · 670 filings